| Structure |
Chemical Name |
CAS |
MF |
 |
Deerasirox Impurity II |
|
|
 |
Brivaracetam Impurity 49 |
|
|
 |
Paroxetine EP Impurity J HCl |
|
|
 |
Brivaracetam Impurity 99 |
|
|
 |
Bendamustine Impurity 39 |
|
|
 |
(R)-4-(((R)-1-carboxy-2-((3-hydroxypropyl)thio)ethyl)amino)-3-hydroxy-4-oxobutanoic acid |
|
|
 |
Hydrazinecarboxamide, 2-(6-hydroxy-1-methyl-1H-indol-5-yl)- |
70063-07-9 |
C10H12N4O2 |
![1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-](/CAS/20210305/GIF/2514742-82-4.gif) |
1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)- |
2514742-82-4 |
C16H10ClFN2O3S |
 |
Crisaborole Impurity 20 |
|
|
 |
(Z)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide |
|
|
![(1S,3R,5S,6R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/) |
(1S,3R,5S,6R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
|
|
 |
Nicergoline EP Impurity IJ |
|
|
 |
Fulvestrant impurityABCDEFGHJKL |
|
|
![2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate](/CAS/20210305/GIF/114696-04-7.gif) |
2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
114696-04-7 |
C24H36O6 |
 |
Isavuconazole Impurity 49 |
|
|
 |
Everolimus EP Impurity E |
1237826-25-3 |
C52H79NO14 |
 |
Edaravone Impurity P4 |
|
|
 |
Canagliflozin Impurity 50 |
|
|
 |
Canagliflozin Impurity 66 |
|
|
 |
Cabozantinib impurity P |
|
|
 |
Rotigotine Impurity 7 |
|
|
 |
Nicorandil Impurity B |
|
|
 |
Cilastatin Impurity 8 |
|
|
 |
Tamsulosin impurity E |
|
C20H28N2O5S |
 |
Flucloxacillin Impurity H |
|
|
 |
Cefminox Impurity 2 |
|
|
 |
Bosutinib Impurity 14 |
|
|
 |
Brivaracetam Impurity 16 |
|
|
 |
Etoricoxib Impurity 41 |
855307-80-1 |
C18H13ClN2O2S |
 |
Fluvoxamine Impurity 10 |
|
|
 |
Nintedanib Impurity 50 |
2410284-90-9 |
C56H52N8O8 |
 |
Olopatadine Impurity 8 |
|
|
 |
Oseltamivir Impurity 36 |
|
|
 |
Palbociclib Impurity 61 |
2222404-53-5 |
C14H20N4O4 |
 |
Palbociclib Impurity 41 |
|
|
 |
Saxagliptin Impurity 8 |
|
|
 |
Tenofovir Impurity 63 |
|
|
 |
Ticagrelor Impurity 99 |
|
|
 |
Ticagrelor Impurity 114 |
|
|
 |
Ticagrelor Impurity 98 |
|
|
 |
Tofacitinib Impurity 118 |
|
|
 |
Trelagliptin Impurity 23 |
|
|
 |
Vildagliptin Impurity 33 |
|
|
 |
Vildagliptin Impurity 44 |
|
|
 |
Voriconazole Impurity 16 |
1157981-64-0 |
C10H7F2N3O |
 |
Itraconazole iMpurity 3 |
|
|
 |
1-(3,5-bis(benzyloxy)phenyl)-2,2-dibromoethan-1-one |
|
C22H18Br2O3 |
 |
Saxagliptin Impurity 7 |
|
|
 |
Cinacalcet Impurity 23 |
|
|
 |
Erlotinib Impurity 24 |
|
|
 |
Ticagrelor Impurity 47 |
|
|
 |
Edaravone Impurity 10 |
|
|
 |
Empagliflozin Impurity 10 |
|
|
 |
Canagliflozin Impurity 10 |
|
|
 |
Fondaparinux Sodium Impurity 10 |
|
|
 |
Oxacillin sodium Impurity E |
|
|
 |
Pregabalin IMpurity |
159029-27-3 |
C7H18N2 |
 |
Valdecoxib 3'-SulfonaMide IMpurity |
1373038-56-2 |
C16H14N2O3S |
 |
(3R,4R)-4-(2,5-Difluorophenyl)-3-Methyl-4-(1H-1,2,4-triazol-1-ylMethyl)-2-oxetanone |
483340-20-1 |
C13H11F2N3O2 |
 |
6,7-DiMethoxy-2-(4-(tetrahydrofuran-2-carbonyl)piperazin-1-yl)quinazolin-4(1H)-one |
1177261-73-2 |
C19H24N4O5 |
![13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid](/CAS/20150408/GIF/229312-33-8.gif) |
13-oxo-1,4,7,10-Tetraazabicyclo[8.2.1]tridecane-4,7-diacetic Acid |
229312-33-8 |
C13H22N4O5 |
![5-{2-[1-(5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol](/CAS/GIF/73837-24-8.gif) |
5-{2-[1-(5-Hydroxy-1,5-dimethyl-hexyl)-7a-methyl-octahydro-inden-4-ylidene]-ethylidene}-4-methylene-cyclohexane-1,3-diol |
73837-24-8 |
C27H44O3 |
![2-エチルアミノ-1-[4-(2-メトキシエチル)フェノキシ]エタノール](/CAS/GIF/109632-08-8.gif) |
2-エチルアミノ-1-[4-(2-メトキシエチル)フェノキシ]エタノール |
109632-08-8 |
C14H23NO3 |
![(Z)-1-(4-ヒドロキシフェニル)-1-[4-[2-(ジメチルアミノ)エトキシ]フェニル]-2-フェニル-1-ブテン](/CAS/GIF/65213-48-1.gif) |
(Z)-1-(4-ヒドロキシフェニル)-1-[4-[2-(ジメチルアミノ)エトキシ]フェニル]-2-フェニル-1-ブテン |
65213-48-1 |
C26H29NO2 |
 |
10-Methoxyiminostilbene-5-carbonylchloride |
28721-08-6 |
C16H12ClNO2 |
 |
6-(3-CHLOROPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE |
4514-54-9 |
C9H8ClN5 |
 |
3-ヒドロキシ-α-メチル-L-チロシンメチル |
18181-08-3 |
C11H15NO4 |
![(6R,7R)-3-(クロロメチル)-7-メトキシ-7-(p-トルオイルアミノ)-8-オキソ-5-オキサ-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸ジフェニルメチル](/CAS/GIF/68314-38-5.gif) |
(6R,7R)-3-(クロロメチル)-7-メトキシ-7-(p-トルオイルアミノ)-8-オキソ-5-オキサ-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸ジフェニルメチル |
68314-38-5 |
C30H27ClN2O6 |
 |
Rivaroxaban Impurity 35 |
|
|
 |
Febuxostat Impurity 67 |
|
|
 |
Riociguat IMpurtiy A |
|
|
 |
Peramivir Impurity C |
|
|
 |
Lincomycin sulfoxide Impurity 6 |
|
|
 |
Metronidazole IMpurity 5 |
|
|
 |
Sulpiride Impurity 5 |
|
|
 |
methyl 3-(4-(3-(ethylamino)-2-hydroxypropoxy)phenyl)propanoate hydrochloride |
|
C15H24ClNO4 |
 |
Tacrolimus Impurity F |
|
|
 |
Cefminox Impurity E |
|
|
 |
Bumetanide iMpurity F |
|
|
 |
イオペントール |
89797-00-2 |
C20H28I3N3O9 |
 |
NIMODIPINE RELATED COMPOUND B (2,6-ジメチル-4-(3-ニトロフェニル)-1,4-ジヒドロピリジン-3,5-ジカルボン酸ビス(2-メトキシエチル)) |
70172-96-2 |
C21H26N2O8 |
 |
1-メチル-2-フェノキシエチルアミン |
35205-54-0 |
C9H13NO |
 |
N-Depiperidin-3-amine Linagliptin Dimer |
2253964-98-4 |
C45H44N14O4 |
![(1R,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic Acid Ethyl Ester](/CAS/20200401/GIF/CB75211668.gif) |
(1R,5R,6S)-5-Hydroxy-7-oxabicyclo[4.1.0]hept-2-ene-3-carboxylic Acid Ethyl Ester |
1476028-68-8 |
C9H12O4 |
 |
(8S,11S,Z)-5-(2-Aminothiazol-4-yl)-11-(3-guanidinopropyl)-2,2-dimethyl-6,9-dioxo-8-((S)-1-(sulfoamino)ethyl)-3-oxa-4,7,10-triazadodec-4-ene-1,12-dioic Acid |
|
C19H31N9O10S2 |
 |
Brepperazole impurity |
|
|
 |
Mupirocin iMpurity 4 |
|
C26H44O9 |
 |
Tenofovirdisoproxil Impurity C |
1878175-82-6 |
C11H17N5O2 |
 |
2052297-80-8 |
2052297-80-8 |
C12H21NO3 |
 |
Pramipexole Impurity L |
|
|
 |
1020151-61-4 |
1020151-61-4 |
C14H23ClO3S |
 |
Nicergoline Impurity M |
|
|
 |
ethyl 2-(4-(tert-butoxy)-3-cyanophenyl)-4-methylthiazole-5- carboxylate |
|
C18H20N2O3S |
![(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro- [1,1'-biphenyl]-4-yl)piperidine-1-carboxylate](/CAS/20200401/GIF/CB75432290.gif) |
(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro- [1,1'-biphenyl]-4-yl)piperidine-1-carboxylate |
|
C32H28FNO5 |
 |
Moxifloxacin Impurity 9 |
|
|
 |
Ticagrelor Impurity 10 |
|
|
 |
Tofacitinib Impurity O |
|
|
 |
Celecoxib Impurity 5 |
|
C17H14F3N3O2S |
 |
Prasugrel Impurity 10 |
|
|
 |
Amlodipine N-Lactoside |
749864-27-5 |
C32H45ClN2O15 |